A mouse study suggests tirzepatide, sold as Mounjaro and Zepbound, may activate calorie-burning brown fat, offering a new understanding of its metabolic benefits.
A six-month trial found that reducing sweet-tasting foods did not curb cravings or improve health markers for diabetes and heart disease.
Researchers have found that misfolded insulin proteins may contribute to diabetes progression, suggesting new treatment strategies by strengthening cellular protein-folding machinery.
New research shows that damaged fat cells can inflame and disappear, disrupting metabolism and leading to diabetes, highlighting the importance of healthy fat tissue.
New research indicates genetic variants may cause GLP-1 drug resistance in about 10% of the population, impacting Type 2 diabetes treatment effectiveness.